FI885807L - Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen - Google Patents

Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen Download PDF

Info

Publication number: FI885807L
Authority: FI; Finland
Prior art keywords: purified; production; biologically active; recombinant human; human csf
Prior art date: 1987-04-16

Application number

FI885807A

Other languages

English (en)

Swedish (sv)

Other versions

FI96872B (fi

FI96872C (fi

FI885807A0 (fi

Inventor

Robert F Halenbeck

Kirston E Koths

Cynthia Cowgill

Walter J Laird

Original Assignee

Cetus Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-04-16

Filing date

1988-12-15

Publication date

1988-12-15

1988-12-15 Application filed by Cetus Corp filed Critical Cetus Corp

1988-12-15 Publication of FI885807L publication Critical patent/FI885807L/fi

1988-12-15 Publication of FI885807A0 publication Critical patent/FI885807A0/fi

1996-05-31 Publication of FI96872B publication Critical patent/FI96872B/fi

1996-09-10 Application granted granted Critical

1996-09-10 Publication of FI96872C publication Critical patent/FI96872C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Analytical Chemistry (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

FI885807A 1987-04-16 1988-12-15 Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen FI96872C (fi)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US4017487A	1987-04-16	1987-04-16
US4017487		1987-04-16
US11400187A	1987-10-27	1987-10-27
US11400187		1987-10-27
US8801189		1988-04-18
PCT/US1988/001189 WO1988008003A1 (en)	1987-04-16	1988-04-18	Production of purified, biologically active, bacterially produced recombinant human csf-1

Publications (4)

Publication Number	Publication Date
FI885807L true FI885807L (fi)	1988-12-15
FI885807A0 FI885807A0 (fi)	1988-12-15
FI96872B FI96872B (fi)	1996-05-31
FI96872C FI96872C (fi)	1996-09-10

Family

ID=26716797

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI885807A FI96872C (fi)	1987-04-16	1988-12-15	Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen

Country Status (10)

Country	Link
EP (2)	EP0818466B1 (fi)
JP (1)	JP2656964B2 (fi)
AT (2)	ATE301133T1 (fi)
AU (1)	AU610182B2 (fi)
BG (1)	BG49827A3 (fi)
DE (2)	DE3856203T2 (fi)
FI (1)	FI96872C (fi)
IL (1)	IL86090A (fi)
NO (1)	NO300067B1 (fi)
WO (1)	WO1988008003A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5650297A (en) *	1986-09-17	1997-07-22	Otsuka Pharmaceutical Co., Ltd.	DNA encoding human colony-stimulating factors
US4931543A (en) *	1987-05-11	1990-06-05	Cetus Corporation	Process for recovering microbially produced interleukin-2
DE68918091T2 (de) *	1988-04-29	1995-04-06	Genetics Institute, Inc., Cambridge, Mass.	Lagerungsstabile zusammensetzungen von homogenem dimerem m-csf.
EP0410751B1 (en) *	1989-07-27	1996-04-10	Denki Kagaku Kogyo Kabushiki Kaisha	Gene encoding M-CSF and related recombinant systems thereof
GB8927546D0 (en) *	1989-12-06	1990-02-07	Ciba Geigy	Process for the production of biologically active tgf-beta
EP0545999B1 (en) *	1990-08-20	1997-06-04	Novo Nordisk A/S	Process for the preparation of biologically active IGF-1 using IGF-1 having an amino-terminal extension
WO1992004382A1 (en) *	1990-09-05	1992-03-19	Bunge (Australia) Pty. Ltd.	Solubilization of proteins in active forms
US5288931A (en) *	1991-12-06	1994-02-22	Genentech, Inc.	Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
WO1993025687A1 (en) *	1992-06-09	1993-12-23	Chiron Corporation	Crystallization of m-csf
AU661914B2 (en) *	1992-08-18	1995-08-10	Jean-Louis Odore	Support structure for a shelter cover
CA2144523A1 (en) *	1993-08-04	1995-02-16	Hugo Grossenbacher	High molecular weight desulphatohirudin
US5407810A (en) *	1993-08-20	1995-04-18	Genentech, Inc.	Aqueous multiple-phase isolation of polypeptide
US5663304A (en) *	1993-08-20	1997-09-02	Genentech, Inc.	Refolding of misfolded insulin-like growth factor-I
TW517059B (en)	1994-07-25	2003-01-11	Ciba Geigy Ag	New process for the production of biologically active protein
FR2796071B1 (fr) *	1999-07-08	2001-09-07	Hoechst Marion Roussel Inc	Procede de purification de facteur de stimulation de colonies de granulocytes
US6808902B1 (en)	1999-11-12	2004-10-26	Amgen Inc.	Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
DE102004041639A1 (de) *	2004-08-27	2006-03-02	Bioceuticals Arzneimittel Ag	Verfahren zur Gewinnung von biologisch aktivem humanen G-CSF aus Inclusion Bodies
WO2011005488A1 (en)	2009-06-22	2011-01-13	Amgen Inc.	Refolding proteins using a chemically controlled redox state
FI3660032T3 (fi)	2009-06-25	2025-12-18	Amgen Inc	Ei-nisäkäsperäisessä järjestelmässä ekspressoitujen proteiinien sieppauspuhdistusmenetelmiä
DE202009019091U1 (de)	2009-12-21	2016-05-23	Agilent Technologies, Inc. - A Delaware Corporation -	Fittingelement mit frontseitiger Einlage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR79124B (fi) *	1982-12-22	1984-10-02	Genentech Inc
DE3689391T2 (de) *	1985-02-05	1994-06-30	Cetus Oncology Corp., Emeryville, Calif.	Rekombinanter koloniestimulierender faktor-1.
FI884877L (fi) *	1986-05-06	1988-10-21	Genetics Inst	Produktion av m-csf.
DK54589A (da) *	1988-02-08	1989-08-09	Otsuka Pharma Co Ltd	Humane kolonistmulerende faktorer

1988
- 1988-04-15 IL IL86090A patent/IL86090A/xx not_active IP Right Cessation
- 1988-04-18 EP EP97202737A patent/EP0818466B1/en not_active Expired - Lifetime
- 1988-04-18 EP EP88904086A patent/EP0309569B1/en not_active Expired - Lifetime
- 1988-04-18 JP JP63503965A patent/JP2656964B2/ja not_active Expired - Lifetime
- 1988-04-18 AT AT97202737T patent/ATE301133T1/de not_active IP Right Cessation
- 1988-04-18 AT AT88904086T patent/ATE167192T1/de not_active IP Right Cessation
- 1988-04-18 WO PCT/US1988/001189 patent/WO1988008003A1/en not_active Ceased
- 1988-04-18 AU AU17124/88A patent/AU610182B2/en not_active Expired
- 1988-04-18 DE DE3856203T patent/DE3856203T2/de not_active Expired - Lifetime
- 1988-04-18 DE DE3856581T patent/DE3856581T2/de not_active Expired - Lifetime
- 1988-12-14 NO NO885555A patent/NO300067B1/no not_active IP Right Cessation
- 1988-12-15 FI FI885807A patent/FI96872C/fi not_active IP Right Cessation
- 1988-12-16 BG BG086469A patent/BG49827A3/xx unknown

Also Published As

Publication number	Publication date
DE3856581D1 (de)	2005-09-29
JP2656964B2 (ja)	1997-09-24
EP0818466A3 (en)	1998-03-25
BG49827A3 (bg)	1992-02-14
EP0818466B1 (en)	2005-08-03
NO885555L (no)	1989-01-11
EP0309569B1 (en)	1998-06-10
EP0818466A2 (en)	1998-01-14
DE3856203T2 (de)	1998-10-08
FI96872B (fi)	1996-05-31
NO300067B1 (no)	1997-04-01
IL86090A0 (en)	1988-09-30
EP0309569A1 (en)	1989-04-05
AU610182B2 (en)	1991-05-16
NO885555D0 (no)	1988-12-14
AU1712488A (en)	1988-11-04
ATE167192T1 (de)	1998-06-15
WO1988008003A1 (en)	1988-10-20
DE3856203D1 (de)	1998-07-16
ATE301133T1 (de)	2005-08-15
FI96872C (fi)	1996-09-10
FI885807A0 (fi)	1988-12-15
DE3856581T2 (de)	2006-05-24
JPH01503440A (ja)	1989-11-22
IL86090A (en)	1993-03-15

Publication	Publication Date	Title
FI885807L (fi)	1988-12-15	Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen
DK151985A (da)	1985-10-07	Humant fysiologisk aktivt polypeptid
FI884924A7 (fi)	1989-04-29	Yhdistelmä-DNA-tekniikalla tuotettuja ihmisimmunoglobuliineja
DK203187D0 (da)	1987-04-21	Human g-csf proteinekspression
IT8619338A0 (it)	1986-02-07	Peptide sintetico ad attivita'interleukina 1 umana.
FR2490675B1 (fr)	1985-11-15	Production microbienne d'interferon de fibroplaste humain
DE3689246D1 (de)	1993-12-09	Physiologisch aktives Polypeptid BUF-3.
DK31088D0 (da)	1988-01-22	Blodkoaguleringsnedsaettende peptidderivater
NO904378D0 (no)	1990-10-10	Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.
EP0218531A3 (en)	1989-07-12	Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
DE3884517D1 (de)	1993-11-04	Biologisch aktive carbonsaeureester.
FI872526L (fi)	1987-12-07	Menetelmä biologisesti aktiivisen plasminogeeniaktivaattorin tuottamiseksi
DK49488D0 (da)	1988-02-01	Anaestesi-praeparat
CA2011008A1 (en)	1990-09-01	Egf variants and pharmaceutical use thereof
IL75828A (en)	1991-06-10	Immobilization by biologically active proteins
DK250088D0 (da)	1988-05-06	Ophthalmologisk praeparat
DE3585097D1 (de)	1992-02-20	Herstellung menschlicher urokinase.
FI891820A7 (fi)	1989-04-17	Biologisesti aktiiviset yhdisteet
IT8423896A0 (it)	1984-12-05	Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
ZA882707B (en)	1989-12-27	Production of purified biologically active,bacterially produced recombinant human csf-1
PT87332A (pt)	1988-05-01	Method of purification of product of expression of recombinant ferment
IT8719420A0 (it)	1987-02-18	Purificazione di interleuchina-1umana ricombinante.
ES2012326A4 (es)	1990-03-16	Monoesteres del acido griseolico, su preparacion y empleo
FR2615369B1 (fr)	1990-02-23	Chaise-canne
FI881870A7 (fi)	1988-10-25	L-fenyylialaniinin valmistus rekombinanttibakteerien avulla.

Legal Events

Date	Code	Title	Description
1996-05-02	BB	Publication of examined application
1996-06-26	GB	Transfer or assigment of application	Owner name: CHIRON CORPORATION
2004-08-31	FG	Patent granted	Owner name: CHIRON CORPORATION
2008-01-23	PC	Transfer of assignment of patent	Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. Free format text: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
2008-05-20	MA	Patent expired